Coeptis Therapeutics, Inc. Notes Payable, Current
Coeptis Therapeutics, Inc. had Notes Payable, Current of $3.62 million as of 2022-09-30, per its 10-Q filed 2022-11-08.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Notes and Loans Payable, Current
us-gaap:NotesPayableCurrent · last filed 2022-11-08
- 2022-09-30: Notes Payable, Current $3.62M.
- 2022-06-30: Notes Payable, Current $3.66M.
- 2022-03-31: Notes Payable, Current $2.17M.
- 2021-12-31: Notes Payable, Current $2.42M.
| Period end | Notes Payable, Current |
|---|---|
| 2022-09-30 | $3.62M 10-Q · filed 2022-11-08 |
| 2022-06-30 | $3.66M 10-Q · filed 2022-08-02 |
| 2022-03-31 | $2.17M 10-Q · filed 2022-05-12 |
| 2021-12-31 | $2.42M 10-Q · filed 2022-11-08 |
| 2021-09-30 | $4.00M 10-Q · filed 2021-11-15 |
| 2021-06-30 | $749.60K 10-Q · filed 2021-08-16 |
| 2021-03-31 | $1.16M 10-Q/A · filed 2021-05-18 |
| 2020-12-31 | $1.28M 10-K · filed 2022-03-11 |